Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,830 | 1,330 | 4,400 | -3,940 | -26,950 |
| Depreciation Amortization | 2,050 | 1,400 | 950 | 480 | 3,140 |
| Other Working Capital | -9,300 | -5,500 | -6,540 | -6,520 | 20,220 |
| Other Operating Activity | -2,940 | -4,840 | -5,550 | 2,020 | 6,180 |
| Operating Cash Flow | $-14,020 | $-7,610 | $-6,740 | $-7,960 | $2,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,540 | -1,610 | -470 | -170 | -1,810 |
| Other Investing Activity | 61,020 | 54,020 | 54,030 | 54,030 | -17,780 |
| Investing Cash Flow | $58,480 | $52,410 | $53,560 | $53,860 | $-19,590 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -65,080 | -65,080 | -65,080 | -65,080 | 3,110 |
| Financing Cash Flow | $-65,080 | $-65,080 | $-65,080 | $-65,080 | $3,110 |
| Exchange Rate Effect | 110 | 60 | 40 | 30 | -460 |
| Beginning Cash Position | 28,860 | 28,860 | 28,860 | 28,860 | 43,210 |
| End Cash Position | 8,360 | 8,640 | 10,640 | 9,710 | 28,860 |
| Net Cash Flow | $-20,500 | $-20,220 | $-18,220 | $-19,150 | $-14,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,020 | -7,610 | -6,740 | -7,960 | 2,590 |
| Free Cash Flow | -14,020 | -7,610 | -6,740 | -7,960 | 2,590 |